CreditAccess Grameen Limited Fine Paid for Delayed Compliance on Board Appointment
CreditAccess Grameen Limited has settled a penalty imposed by the BSE Limited due to a delay in appointing a Non-Executive Chairperson. The…
Balkrishna Industries Limited CRISIL Assigns AA+/Stable Rating to ₹750 Crore NCDs
Balkrishna Industries Limited (BKT) has secured a credit rating of CRISIL AA+/Stable for its proposed ₹750 Crore Non-Convertible Debentures…
Balkrishna Industries Limited CRISIL Reaffirms Ratings on Bank Facilities and Commercial Paper
CRISIL Ratings has reaffirmed its ratings for Balkrishna Industries Limited (BIL) facilities as of February 27, 2026. The Long Term Rating for…
IRCON International Limited Stock Exchanges Impose Fine for Board Composition Non-Compliance Q3 FY26
IRCON International Limited has been penalized by both the NSE and BSE for non-compliance regarding the composition of its Board and…
Ramkrishna Forgings Limited NCLT Approves Scheme of Amalgamation for Subsidiaries
The National Company Law Tribunal (NCLT), Kolkata Bench, has approved the Scheme of Amalgamation involving three wholly-owned subsidiaries of…
Polycab India Limited Disclosure on Scheme of Arrangement Approved by NCLT
Polycab India Limited has announced the approval of its Scheme of Arrangement by the National Company Law Tribunal (NCLT). This scheme…
NTPC Limited Imposition of Fine by NSE & BSE for Q3 FY2025-26
NTPC Limited has received notices from the NSE and BSE imposing a fine of ₹5,42,800/- each for non-compliance with Board composition…
Caplin Point Laboratories Subsidiary Receives Final USFDA Approval for Desmopressin Acetate Injection
Caplin Steriles Limited, a subsidiary of Caplin Point Laboratories, secured final approval from the USFDA for its Abbreviated New Drug…
ICICI Bank Board Approves Purchase of Up to 2.0% Additional Shareholding in ICICI Prudential Life Insurance
The Board of Directors of ICICI Bank Limited concluded its meeting on February 28, 2026, approving the purchase of up to 2.0% additional…
Zydus Lifesciences USFDA Final Approvals for Ivermectin and Dapsone Tablets
Zydus Lifesciences announced it has received final approvals from the USFDA for two generic drug formulations: Ivermectin Tablets USP, 3 mg,…